INDIAN PHARMA SECTOR
Unveiling the $3.5 Billion Surge: Q3 2025 Highlights in India’s Pharma and Healthcare Sector
The Indian pharma and healthcare sector saw a significant boost in the third quarter of 2025, with deals totaling $3.5 ... Read more
Why US Reliance on Indian Generic Drugs is Unavoidable: Insights from Natco Pharma CEO Rajiv Nannapaneni
Hyderabad: Rajiv Nannapaneni, the CEO of Natco Pharma, believes the Indian pharmaceutical sector is well-positioned despite new trade tariffs from ... Read more
